Cargando…

Advances in the Use of Regulatory T-Cells for the Prevention and Therapy of Graft-vs.-Host Disease

Regulatory T (Tregs) cells play a crucial role in immunoregulation and promotion of immunological tolerance. Adoptive transfer of these cells has therefore been of interest in the field of bone marrow and solid organ transplantation, autoimmune diseases and allergy medicine. In bone marrow transplan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramlal, Reshma, Hildebrandt, Gerhard C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489809/ https://www.ncbi.nlm.nih.gov/pubmed/28536366 http://dx.doi.org/10.3390/biomedicines5020023

Ejemplares similares

Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges
por: Hefazi, Mehrdad, et al.
Publicado: (2021)

Novel regulatory therapies for prevention of Graft-versus-host disease
por: Leventhal, Joseph, et al.
Publicado: (2012)

Mast Cell Involvement in Fibrosis in Chronic Graft-Versus-Host Disease
por: Strattan, Ethan, et al.
Publicado: (2021)

Mast Cells Are Mediators of Fibrosis and Effector Cell Recruitment in Dermal Chronic Graft-vs.-Host Disease
por: Strattan, Ethan, et al.
Publicado: (2019)

B regulatory cells and monocyte subpopulations in patients with chronic graft-vs-host disease
por: Babić, Antonija, et al.
Publicado: (2021)

Myocarditis Concurrent with Sweet Syndrome: A Presentation of Acute Myeloid Leukemia
por: Burkeen, Christopher G., et al.
Publicado: (2021)

Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease
por: Thangavelu, Govindarajan, et al.
Publicado: (2019)

The lung function score and its components as predictors of overall survival and chronic graft-vs-host disease after allogeneic stem cell transplantation
por: Ditz, Diana, et al.
Publicado: (2016)

Virotherapy as Potential Adjunct Therapy for Graft-Vs-Host Disease
por: Villa, Nancy Y., et al.
Publicado: (2018)

S242: MAST CELLS ARE MEDIATORS OF INFLAMMATORY EFFECTOR CELL RECRUITMENT AND FIBROSIS IN DERMAL CHRONIC GRAFT-VERSUS-HOST DISEASE
por: Palaniyandi, Senthilnathan, et al.
Publicado: (2023)

Microbiome: an emerging new frontier in graft‑versus‑host disease
por: Kumari, Reena, et al.
Publicado: (2020)

Metabolic Reprogramming—A New Era How to Prevent and Treat Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Has Begun
por: Kumari, Reena, et al.
Publicado: (2020)

Role of STAT3 in regulatory T lymphocyte plasticity during acute graft-vs.-host-disease
por: Fujino, Masayuki, et al.
Publicado: (2013)

Third-party regulatory T cells prevent murine acute graft-versus-host disease
por: Lim, Jung-Yeon, et al.
Publicado: (2018)

Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease
por: Le, Hongnga T., et al.
Publicado: (2020)

Editorial: Regulatory T cells in graft versus host disease
por: Rodríguez-Gil, Alfonso, et al.
Publicado: (2023)

Macrophage regulation of graft-vs-host disease
por: Hong, Ya-Qun, et al.
Publicado: (2020)

Post-Transplant Cyclophosphamide for the Prevention of Graft-vs.-Host Disease in Allogeneic Hematopoietic Cell Transplantation: A Guide to Management for the Advanced Practitioner
por: Kachur, Ekaterina, et al.
Publicado: (2023)

Granzyme A Is Required for Regulatory T-Cell Mediated Prevention of Gastrointestinal Graft-versus-Host Disease
por: Velaga, Sarvari, et al.
Publicado: (2015)

Acute Graft-vs.-Host Disease-Associated Endothelial Activation in vitro Is Prevented by Defibrotide
por: Martinez-Sanchez, Julia, et al.
Publicado: (2019)

Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host disease
por: Sánchez-Ortega, Isabel, et al.
Publicado: (2016)

Immunophenotypic characteristics of multipotent mesenchymal stromal cells that affect the efficacy of their use in the prevention of acute graft vs host disease
por: Petinati, Nataliya, et al.
Publicado: (2020)

Prevention of acute graft-vs.-host disease by targeting glycolysis and mTOR pathways in activated T cells
por: Zhou, Rui-Qing, et al.
Publicado: (2022)

The Role of Regulatory T Cells in the Biology of Graft Versus Host Disease
por: Beres, Amy J., et al.
Publicado: (2013)

THE ALLOGENEIC EFFECT IN INBRED MICE : IV. REGULATORY INFLUENCES OF GRAFT-VS.-HOST REACTIONS ON HOST T LYMPHOCYTE FUNCTIONS
por: Osborne, David P., et al.
Publicado: (1973)

Can Graft vs. Leukemia Effect Be Uncoupled From Graft vs. Host Disease? An Examination of Proportions
por: Krieger, Elizabeth, et al.
Publicado: (2020)

Dendritic Cell Regulation of Graft-Vs.-Host Disease: Immunostimulation and Tolerance
por: Yu, Hongshuang, et al.
Publicado: (2019)

Emerging translational strategies and challenges for enhancing regulatory T cell therapy for graft-versus-host disease
por: Hippen, Keli L., et al.
Publicado: (2022)

Dendritic cells induce antigen-specific regulatory T cells that prevent graft versus host disease and persist in mice
por: Sela, Uri, et al.
Publicado: (2011)

Targeting the Human T-Cell Inducible COStimulator Molecule with a Monoclonal Antibody Prevents Graft-vs-Host Disease and Preserves Graft vs Leukemia in a Xenograft Murine Model
por: Burlion, Aude, et al.
Publicado: (2017)

Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib
por: Rodríguez-Gil, Alfonso, et al.
Publicado: (2022)

Treatment of Graft-versus-Host Disease with Naturally Occurring T Regulatory Cells
por: Trzonkowski, Piotr, et al.
Publicado: (2013)

Graft-vs-Host Disease Colitis After Lung Transplant
por: Kanthasamy, Kavin, et al.
Publicado: (2019)

Biomarkers of graft-vs-host disease: Understanding and applications for the future
por: Nagasawa, Masayuki
Publicado: (2021)

Post-transplant cyclophosphamide prevents xenogeneic graft-versus-host disease while depleting proliferating regulatory T cells
por: Ritacco, Caroline, et al.
Publicado: (2023)

Bone marrow provides an environment that prevents suppression of therapeutic graft-vs.-tumor immunity by regulatory T cells
por: Guichelaar, Teun, et al.
Publicado: (2013)

Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention
por: Hamilton, Betty K., et al.
Publicado: (2023)

Human multipotent adult progenitor cells effectively reduce graft‐vs‐host disease while preserving graft‐vs‐leukemia activity
por: Metheny, Leland, et al.
Publicado: (2021)

An Essential Role of Innate Lymphoid Cells in the Pathophysiology of Graft-vs.-Host Disease
por: Shao, Liang, et al.
Publicado: (2019)

GRAFT-VS.-HOST REACTION IN TISSUE CULTURE
por: Auerbach, Robert, et al.
Publicado: (1973)

Cannot write session to /tmp/vufind_sessions/sess_5jtpie7994kkan8223auplkkb4